Cargando…
Epidermal growth factor receptor levels are reduced in mice with targeted disruption of the protein kinase A catalytic subunit
BACKGROUND: Epidermal Growth Factor Receptor (EGFR) is a key target molecule in current treatment of several neoplastic diseases. Hence, in order to develop and improve current drugs targeting EGFR signalling, an accurate understanding of how this signalling pathway is regulated is required. It has...
Autores principales: | Oksvold, Morten P, Funderud, Ane, Kvissel, Anne-Katrine, Skarpen, Ellen, Henanger, Heidi, Huitfeldt, Henrik S, Skålhegg, Bjørn S, Ørstavik, Sigurd |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2324083/ https://www.ncbi.nlm.nih.gov/pubmed/18380891 http://dx.doi.org/10.1186/1471-2121-9-16 |
Ejemplares similares
-
Identification, cloning and characterization of a novel 47 kDa murine PKA C subunit homologous to human and bovine Cβ2
por: Funderud, Ane, et al.
Publicado: (2006) -
Protein kinase A type I activates a CRE-element more efficiently than protein kinase A type II regardless of C subunit isoform
por: Stakkestad, Øystein, et al.
Publicado: (2011) -
The Molecular Basis for Specificity at the Level of the Protein Kinase a Catalytic Subunit
por: Søberg, Kristoffer, et al.
Publicado: (2018) -
Two Cellular Protein Kinases, DNA-PK and PKA, Phosphorylate the Adenoviral L4-33K Protein and Have Opposite Effects on L1 Alternative RNA Splicing
por: Törmänen Persson, Heidi, et al.
Publicado: (2012) -
Evolutionary Paths of the cAMP-Dependent Protein Kinase (PKA) Catalytic Subunits
por: Søberg, Kristoffer, et al.
Publicado: (2013)